benefit of two of the newer drugs for osteoporosis

There's good news about the benefit of two of the newer drugs for osteoporosis...Evista (raloxifene) and Fosamax (alendronate).

Evista has now been shown to prevent FRACTURES...initially it was shown just to increase bone density.

Evista cuts the risk of spinal fractures in half...in postmenopausal women who take it for two years.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote